158 related articles for article (PubMed ID: 25418557)
1. Challenges and opportunities for cell line secretomes in cancer proteomics.
Méndez O; Villanueva J
Proteomics Clin Appl; 2015 Apr; 9(3-4):348-57. PubMed ID: 25418557
[TBL] [Abstract][Full Text] [Related]
2. Tissue culture-based breast cancer biomarker discovery platform.
Kulasingam V; Diamandis EP
Int J Cancer; 2008 Nov; 123(9):2007-12. PubMed ID: 18712711
[TBL] [Abstract][Full Text] [Related]
3. Pathway-based biomarker search by high-throughput proteomics profiling of secretomes.
Lawlor K; Nazarian A; Lacomis L; Tempst P; Villanueva J
J Proteome Res; 2009 Mar; 8(3):1489-503. PubMed ID: 19199430
[TBL] [Abstract][Full Text] [Related]
4. Batch effects correction improves the sensitivity of significance tests in spectral counting-based comparative discovery proteomics.
Gregori J; Villarreal L; Méndez O; Sánchez A; Baselga J; Villanueva J
J Proteomics; 2012 Jul; 75(13):3938-51. PubMed ID: 22588121
[TBL] [Abstract][Full Text] [Related]
5. Secretome proteomics for discovery of cancer biomarkers.
Makridakis M; Vlahou A
J Proteomics; 2010 Nov; 73(12):2291-305. PubMed ID: 20637910
[TBL] [Abstract][Full Text] [Related]
6. Unconventional secretion is a major contributor of cancer cell line secretomes.
Villarreal L; Méndez O; Salvans C; Gregori J; Baselga J; Villanueva J
Mol Cell Proteomics; 2013 May; 12(5):1046-60. PubMed ID: 23268930
[TBL] [Abstract][Full Text] [Related]
7. Secretome analysis using a hollow fiber culture system for cancer biomarker discovery.
Chiu KH; Chang YH; Liao PC
Biochim Biophys Acta; 2013 Nov; 1834(11):2285-92. PubMed ID: 23376430
[TBL] [Abstract][Full Text] [Related]
8. Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer.
Katsila T; Juliachs M; Gregori J; Macarulla T; Villarreal L; Bardelli A; Torrance C; Elez E; Tabernero J; Villanueva J
Clin Cancer Res; 2014 Dec; 20(24):6346-56. PubMed ID: 25324142
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis to select cancer candidate biomarkers to targeted validation.
Kawahara R; Meirelles GV; Heberle H; Domingues RR; Granato DC; Yokoo S; Canevarolo RR; Winck FV; Ribeiro AC; Brandão TB; Filgueiras PR; Cruz KS; Barbuto JA; Poppi RJ; Minghim R; Telles GP; Fonseca FP; Fox JW; Santos-Silva AR; Coletta RD; Sherman NE; Paes Leme AF
Oncotarget; 2015 Dec; 6(41):43635-52. PubMed ID: 26540631
[TBL] [Abstract][Full Text] [Related]
10. Proteomics-driven cancer biomarker discovery: looking to the future.
Simpson RJ; Bernhard OK; Greening DW; Moritz RL
Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
[TBL] [Abstract][Full Text] [Related]
11. Tumor interstitial fluid - a treasure trove of cancer biomarkers.
Gromov P; Gromova I; Olsen CJ; Timmermans-Wielenga V; Talman ML; Serizawa RR; Moreira JM
Biochim Biophys Acta; 2013 Nov; 1834(11):2259-70. PubMed ID: 23416532
[TBL] [Abstract][Full Text] [Related]
12. The cancer cell secretome: a good source for discovering biomarkers?
Pavlou MP; Diamandis EP
J Proteomics; 2010 Sep; 73(10):1896-906. PubMed ID: 20394844
[TBL] [Abstract][Full Text] [Related]
13. Sieving through the cancer secretome.
Lin Q; Tan HT; Lim HS; Chung MC
Biochim Biophys Acta; 2013 Nov; 1834(11):2360-71. PubMed ID: 23376431
[TBL] [Abstract][Full Text] [Related]
14. Glioma proteomics: status and perspectives.
Niclou SP; Fack F; Rajcevic U
J Proteomics; 2010 Sep; 73(10):1823-38. PubMed ID: 20332038
[TBL] [Abstract][Full Text] [Related]
15. Interstitial fluid-a reflection of the tumor cell microenvironment and secretome.
Haslene-Hox H; Tenstad O; Wiig H
Biochim Biophys Acta; 2013 Nov; 1834(11):2336-46. PubMed ID: 23376185
[TBL] [Abstract][Full Text] [Related]
16. Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry.
Mathivanan S; Ji H; Tauro BJ; Chen YS; Simpson RJ
J Proteomics; 2012 Dec; 76 Spec No.():141-9. PubMed ID: 22796352
[TBL] [Abstract][Full Text] [Related]
17. High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.
Jimenez CR; Piersma S; Pham TV
Biomark Med; 2007 Dec; 1(4):541-65. PubMed ID: 20477373
[TBL] [Abstract][Full Text] [Related]
18. Cancer secretomes and their place in supplementing other hallmarks of cancer.
Patel S; Ngounou Wetie AG; Darie CC; Clarkson BD
Adv Exp Med Biol; 2014; 806():409-42. PubMed ID: 24952195
[TBL] [Abstract][Full Text] [Related]
19. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum.
Piersma SR; Fiedler U; Span S; Lingnau A; Pham TV; Hoffmann S; Kubbutat MH; Jiménez CR
J Proteome Res; 2010 Apr; 9(4):1913-22. PubMed ID: 20085282
[TBL] [Abstract][Full Text] [Related]
20. Analysis of secreted proteins.
Severino V; Farina A; Chambery A
Methods Mol Biol; 2013; 1002():37-60. PubMed ID: 23625393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
